Neurotech International Gets US FDA Rare Pediatric Disease Designation For NTI164
ReutersOct 8, 2025 1:26 AM
Oct 8 (Reuters) - Neurotech International Ltd NTI.AX:
US FDA RARE PEDIATRIC DISEASE DESIGNATION FOR NTI164 IN RETT SYNDROME
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Synopsys (SNPS): Strategic Opportunities and Risks Amid 40% Drawdown
Chip giant Synopsys teetering on the edge? The ultimate "pick-and-shovel" supplier in the AI frenzy, but hammered by China's sudden market freeze and export clamps, sending shares crashing 40%! Is that $35 billion Ansys mega-deal a rescue rope or a bigger sinkhole? Dive into the EDA powerhouse's naiTradingKey
57 minutes ago
-8a7a081ca049441dae56d6b7cc6440c4.jpg)
FOMC October Meeting Minutes: How Should Investors Respond?
In the context of the U.S. government shutdown and a period of limited economic data, the Federal Reserve’s release of its latest monetary policy meeting minutes and officials’ statements on 8 October will be particularly significant.TradingKey
Tue, Oct 7
U.S. Government Shutdown Commentary: Is a Stock Market Crash Imminent? Will Gold Prices Continue to Surge?
TradingKey - On 1 October 2025, the U.S. federal government officially entered a shutdown, impacting various asset classes. This article analyses two key markets most affected—U.S. equities and gold—to help investors identify potential opportunities.TradingKey
Wed, Oct 1
Broadcom Q3 FY2025 Earnings Review: AI Surge and VMware Synergy Fuel Record Performance
TradingKey - Broadcom Inc. (NASDAQ: AVGO) delivered a strong fiscal Q3 2025, with results driven by AI networking strength and continued VMware integration. Revenue and EPS both topped expectations, reinforcing the company’s role as an essential player in the AI infrastructure buildout.TradingKey
Fri, Sep 5
ASML Q2 FY2025 Earnings Review: Strong Growth and High-NA EUV Breakthrough Shadowed by 2026 Uncertainty
ASML Holding N.V. (NASDAQ: ASML) released its Q2 FY2025 earnings on July 16, 2025, exceeding market expectations with robust net sales and net bookings, though the stock fell around 10% due to cautious guidance for 2026 amid geopolitical uncertainties.TradingKey
Mon, Jul 14
